Menu

Tesamorelin

0.0
0 orders In stock
550.40

Tesamorelin

Type:
Medicine
Prescription Required:
Login to check prescription requirements.
Concentration:
1 mg/0.3 ml
Form:
Vial
Dosage:
Inject 1mg to 2mg subcutaneously daily.

Save

Tesamorelin

Key Features
  • Endogenous stimulation - Upstream Strategy
  • Night-Aligned Routine - Bedtime Friendly
  • SubQ At-Home - Insulin Syringe
  • IGF-1 Alignment - Recovery Signals
  • Repair-Backing - Train-Recover-Repeat
  • Adjustable volume - 1–2 mg Range
Product Specifications
Concentration: 1 mg/0.3 ml
Form: Vial
Dosage: Inject 1mg to 2mg subcutaneously daily.
Manufactured Date: 18 Oct, 2025
Shelf Life: 100 Days
SKU: tes_1ba4a6
Category: Growth Hormone Support
Vendor: PTNL
Use Cases
  • Excess abdominal fat reduction
  • Reduction of lipodystrophy
How to Use Tesamorelin

How to Use — Step-by-Step (Subcutaneous, Daily)

Preparation

  • Wash Hands – Soap and water.

  • Gather Supplies – Vial, alcohol swabs, insulin syringe, sharps container.

  • Choose Time – Use at a consistent daily time (many prefer bedtime, often on an empty stomach 2–3 hours after last meal unless directed otherwise).

Site Prep

  • Select Site – Abdomen (rotate sites), thigh, or upper arm.

  • Clean Skin – Alcohol swab; let air-dry.

Draw Dose

  • Inspect Vial – Clear, particle-free solution.

  • Measure – Draw the volume that matches your 1–2 mg target (see quick volume guide above).

  • De-air – Tap syringe; expel bubbles.

Inject

  • Pinch Skin – Small fold.

  • Insert – ~45° into subcutaneous tissue.

  • Inject Slowly – Depress plunger; withdraw at same angle.

  • Press – Light pressure with gauze; do not rub.

After

  • Dispose Safely – Sharps container.

  • Record – Optional: note dose/time and injection site to support rotation.

Customer Questions & Answers

    No reviews yet. Be the first to write one!

Customer Reviews

0.0

out of 5.0
5 Star (0.0%)
4 Star (0.0%)
3 Star (0.0%)
2 Star (0.0%)
1 Star (0.0%)
How are ratings calculated?
Possible Side Effects

Possible Side Effects

Common (usually mild/transient)

  • Injection-site redness/itching, mild bruising or pain

  • Water retention/edema, arthralgia, muscle aches

  • Headache, nausea, fatigue, flushing

  • Paresthesias/tingling (carpal-tunnel–like)

Metabolic / Monitor

  • Increased IGF-1 (clinician will monitor)

  • Glucose changes: appetite shifts, fasting glucose/insulin changes—use added caution if you have diabetes/insulin resistance

Serious (stop & seek care; contact your clinician)

  • Severe allergic reaction (hives, facial swelling, wheeze)

  • Marked edema, shortness of breath, chest symptoms

  • Persistent, severe joint pain or numbness/weakness of hands

Not exhaustive. If effects are severe, persistent, or unusual, discontinue and contact your clinician.

Additional Information

Additional Information

What is Tesamorelin?
A growth hormone–releasing hormone (GHRH) analogue used under medical supervision to stimulate endogenous GH secretion, with downstream IGF-1 support.

How Does It Work?

  • Pulsatile GH Stimulation – Encourages physiologic GH release, often aligning with nocturnal rhythms.

  • Recovery & Composition – Protocols commonly target recovery, sleep quality, and favorable body-composition trends alongside training/nutrition.

Who Should Not Use It?

  • Pregnancy/breastfeeding, minors, or anyone with active malignancy or hypersensitivity to components.

  • Use caution in uncontrolled hypertension, sleep apnea, significant edema, diabetes/insulin resistance, or carpal tunnel history—requires clinician oversight.

Clinical Supervision
Your clinician may monitor IGF-1, fasting glucose/insulin, lipids, BP, and symptom response; dose adjustments are individualized.

Shipping Information

Shipping & Cold Storage

  • Refrigerate 2–8 °C (35–46 °F); do not freeze; protect from light.

  • Keep in original packaging.

  • If supplied/reconstituted by the pharmacy, follow the beyond-use date (BUD) on the label.

  • Cold-chain shipping with ice packs; on arrival, refrigerate promptly and inspect for leaks or temperature breach.

PTNL
PTNL
62 Products

Best for Weightloss

  • 100% Authentic
  • 100 Days Return
  • 100 Months Warranty
  • Address: 7 Dell Rise, St Albans, United Kingdom
  • Contact Seller: +44 7789456012

Chat response

100%

Shipping

100%

Authenticity

100%

Become a Vendor? Register now

Frequently Asked Questions

A consistent daily time; many clinicians prefer bedtime (often 2–3 hours after the last meal).

Sleep/recovery changes may appear in 1–2 weeks; composition/performance trends typically 4–8+ weeks with training and nutrition.

Your clinician will monitor IGF-1 and adjust dose if needed.

Edema and carpal-tunnel–like symptoms can occur; report persistent symptoms for potential dose/timing adjustments.

No strict rules, but many protocols avoid protein/carbs 2–3 hours pre-dose to align with GH rhythms.

Only under clinical supervision; avoid unsupervised multi-agent GH-axis stacks.

Skip and resume the next day—do not double dose.

Pregnant/breastfeeding individuals, minors, those with active cancer, or significant uncontrolled CV/edema issues without specialist oversight.

Use an insulated bag with ice packs; keep upright; do not freeze; protect from light.